The latest research showed that Axl was used to control the acquired TKI resistance of NSCLC.5, 6, 11, 12, 13, 14 Anexelekto (Axl) is a member of the receptor tyrosine kinase subfamily. This evidence concerns the gene AXL and non-small cell lung carcinoma.